Rapid production of clinical‐grade SARS‐CoV‐2 specific T cells

OBJECTIVES: To determine whether the frequencies of SARS‐CoV‐2‐specific T cells are sufficiently high in the blood of convalescent donors and whether it is technically feasible to manufacture clinical‐grade products overnight for T‐cell therapy and assessment of COVID‐19 immunity. METHODS: One unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Wing, Soh, Teck Guan, Linn, Yeh Ching, Low, Jenny Guek‐Hong, Loh, Jiashen, Chan, Marieta, Chng, Wee Joo, Koh, Liang Piu, Poon, Michelle Li‐Mei, Ng, King Pan, Kuick, Chik Hong, Tan, Thuan Tong, Tan, Lip Kun, Seng, Michaela Su‐fern
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404427/
https://www.ncbi.nlm.nih.gov/pubmed/32838213
http://dx.doi.org/10.1002/acg2.101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404427/
https://www.ncbi.nlm.nih.gov/pubmed/32838213
http://dx.doi.org/10.1002/acg2.101

Ejemplares similares